Cumberland Partners LTD Grifols Sa Transaction History

Cumberland Partners LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$15.15 - $19.78 $871,125 - $1.14 Million	-57,500 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$16.86 - $19.67 $84,300 - $98,350	5,000 Added 9.52%	57,500 $1.06 Million
Q3 2020 Nov 03, 2020	BUY	$15.4 - $20.16 $808,500 - $1.06 Million	52,500 New	52,500 $911,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Cumberland Partners LTD with notifications on news.